[Federal Register Volume 85, Number 89 (Thursday, May 7, 2020)]
[Notices]
[Page 27248]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-09702]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-639]


Bulk Manufacturer of Controlled Substances Application: Alcami 
Wisconsin Corporation

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before July 6, 2020.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on March 13, 2020, Alcami Wisconsin Corporation, 
W130N10497 Washington Drive, Germantown, Wisconsin 53022-4448, applied 
to be registered as a bulk manufacturer of the following basic 
class(es) of controlled substances:

------------------------------------------------------------------------
        Controlled substance            Drug code          Schedule
------------------------------------------------------------------------
Marihuana Extract..................            7350  I
Marihuana..........................            7360  I
Tetrahydrocannabinols..............            7370  I
5-Methoxy-N-N-dimethyltryptamine...            7431  I
Thebaine...........................            9333  II
Alfentanil.........................            9737  II
------------------------------------------------------------------------

    The company plans to provide bulk active pharmaceutical ingredient 
to support clinical trials. In reference to drug codes 7350 Marihuana 
extract, 7360 Marihuana, and 7370 Tetrahydrocannabinols, the company 
plans to manufacture these substances synthetically. No other 
activities for these drug codes are authorized for this registration.

William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-09702 Filed 5-6-20; 8:45 am]
 BILLING CODE 4410-09-P